Helicobacter pylori in health and disease.
暂无分享,去创建一个
[1] S. Brandt,et al. Importance of EGF receptor, HER2/Neu and Erk1/2 kinase signalling for host cell elongation and scattering induced by the Helicobacter pylori CagA protein: antagonistic effects of the vacuolating cytotoxin VacA , 2009, Cellular microbiology.
[2] F. Islami,et al. Helicobacter pylori and Esophageal Cancer Risk: A Meta-analysis , 2008, Cancer Prevention Research.
[3] K. Ottemann,et al. Recombination-Based In Vivo Expression Technology Identifies Helicobacter pylori Genes Important for Host Colonization , 2008, Infection and Immunity.
[4] Anders F. Andersson,et al. Comparative Analysis of Human Gut Microbiota by Barcoded Pyrosequencing , 2008, PloS one.
[5] M. Rugge,et al. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. , 2008, Gastroenterology.
[6] M. Blaser,et al. Leptin and ghrelin in relation to Helicobacter pylori status in adult males. , 2008, The Journal of clinical endocrinology and metabolism.
[7] K. Robinson,et al. Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses , 2008, Gut.
[8] C. Bevins,et al. Helicobacter pylori induces an antimicrobial response in rhesus macaques in a cag pathogenicity island-dependent manner. , 2008, Gastroenterology.
[9] K. Hardie,et al. Functional association between the Helicobacter pylori virulence factors VacA and CagA. , 2008, Journal of medical microbiology.
[10] R. Lorenz,et al. Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. , 2008, Gastroenterology.
[11] Naomi Ohnishi,et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse , 2008, Proceedings of the National Academy of Sciences.
[12] D. Busch,et al. Integrin subunit CD18 Is the T-lymphocyte receptor for the Helicobacter pylori vacuolating cytotoxin. , 2008, Cell host & microbe.
[13] Yu Chen,et al. Does Helicobacter pylori protect against asthma and allergy? , 2008, Gut.
[14] Yu Chen,et al. Helicobacter pylori colonization is inversely associated with childhood asthma. , 2008, The Journal of infectious diseases.
[15] David A. Baltrus,et al. Natural Transformation Increases the Rate of Adaptation in the Human Pathogen Helicobacter pylori , 2007, Evolution; international journal of organic evolution.
[16] Roland Hartig,et al. Helicobacter exploits integrin for type IV secretion and kinase activation , 2007, Nature.
[17] M. Blaser,et al. The equilibria that allow bacterial persistence in human hosts , 2007, Nature.
[18] Mark S. Sundrud,et al. Helicobacter pylori Vacuolating Cytotoxin Inhibits Activation-Induced Proliferation of Human T and B Lymphocyte Subsets1 , 2007, The Journal of Immunology.
[19] G. Rieder,et al. Helicobacter pylori dampens gut epithelial self-renewal by inhibiting apoptosis, a bacterial strategy to enhance colonization of the stomach. , 2007, Cell host & microbe.
[20] M. S. McClain,et al. Crystal structure of the Helicobacter pylori vacuolating toxin p55 domain , 2007, Proceedings of the National Academy of Sciences.
[21] M. Plummer,et al. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. , 2007, Journal of the National Cancer Institute.
[22] M. Mohagheghi,et al. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. , 2007, Gastroenterology.
[23] M. Blaser,et al. The association of gastric leptin with oesophageal inflammation and metaplasia , 2007, Gut.
[24] Kalyani Putty,et al. Helicobacter pylori Evolution: Lineage- Specific Adaptations in Homologs of Eukaryotic Sel1-Like Genes , 2007, PLoS Comput. Biol..
[25] C. Josenhans,et al. Helicobacter pylori evolution and phenotypic diversification in a changing host , 2007, Nature Reviews Microbiology.
[26] C. Obuse,et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity , 2007, Nature.
[27] M. Diamond,et al. Herpesvirus latency confers symbiotic protection from bacterial infection , 2007, Nature.
[28] C. Prinz,et al. Inhibition of T-Cell Proliferation by Helicobacter pylori γ-Glutamyl Transpeptidase , 2007 .
[29] Yu Chen,et al. Inverse associations of Helicobacter pylori with asthma and allergy. , 2007, Archives of internal medicine.
[30] Daniel Falush,et al. An African origin for the intimate association between humans and Helicobacter pylori , 2007, Nature.
[31] M. Blaser,et al. Molecular analysis of human forearm superficial skin bacterial biota , 2007, Proceedings of the National Academy of Sciences.
[32] C. Prinz,et al. Inhibition of T-cell proliferation by Helicobacter pylori gamma-glutamyl transpeptidase. , 2007, Gastroenterology.
[33] M. Ege,et al. The asthma epidemic. , 2006, The New England journal of medicine.
[34] N. Salama,et al. Identification of Helicobacter pylori Genes That Contribute to Stomach Colonization , 2006, Infection and Immunity.
[35] M. Blaser,et al. Bacterial populations as perfect gases: genomic integrity and diversification tensions in Helicobacter pylori , 2006, Nature Reviews Microbiology.
[36] T. Haggerty,et al. Gastroenteritis and Transmission of Helicobacter pylori Infection in Households , 2006, Emerging infectious diseases.
[37] H. Algood,et al. Resistance of Primary Murine CD4+ T Cells to Helicobacter pylori Vacuolating Cytotoxin , 2006, Infection and Immunity.
[38] M. Blaser. Who are we? , 2006, EMBO reports.
[39] H. Algood,et al. Helicobacter pylori Persistence: an Overview of Interactions between H. pylori and Host Immune Defenses , 2006, Clinical Microbiology Reviews.
[40] H. Mollenkopf,et al. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori , 2006, Nature Medicine.
[41] R. Maier,et al. The diverse antioxidant systems of Helicobacter pylori , 2006, Molecular microbiology.
[42] M. Pop,et al. Metagenomic Analysis of the Human Distal Gut Microbiome , 2006, Science.
[43] H. Mollenkopf,et al. Characterization of the ArsRS Regulon of Helicobacter pylori, Involved in Acid Adaptation , 2006, Journal of bacteriology.
[44] L. Bravo,et al. Effects of a new Helicobacter pylori infection on height and weight in Colombian children. , 2006, Annals of epidemiology.
[45] J. Atherton,et al. The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. , 2006, Annual review of pathology.
[46] Elisabeth M Bik,et al. Molecular analysis of the bacterial microbiota in the human stomach. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[47] M. Blaser,et al. Bacterial biota in reflux esophagitis and Barrett's esophagus. , 2005, World journal of gastroenterology.
[48] F. Bagnoli,et al. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[49] Christian Kraft,et al. Gain and Loss of Multiple Genes During the Evolution of Helicobacter pylori , 2005, PLoS genetics.
[50] M. Blaser,et al. Helicobacter pylori and overweight status in the United States: data from the Third National Health and Nutrition Examination Survey. , 2005, American journal of epidemiology.
[51] J. Dubochet,et al. High resolution structural analysis of Helicobacter pylori VacA toxin oligomers by cryo-negative staining electron microscopy. , 2005, Journal of structural biology.
[52] M. Washington,et al. Activation of β-catenin by carcinogenic Helicobacter pylori , 2005 .
[53] H. Aburatani,et al. Functional antagonism between Helicobacter pylori CagA and vacuolating toxin VacA in control of the NFAT signaling pathway in gastric epithelial cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[54] A. Aderem,et al. Evasion of Toll-like receptor 5 by flagellated bacteria. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[55] E. Purdom,et al. Diversity of the Human Intestinal Microbial Flora , 2005, Science.
[56] Ronald W. Davis,et al. Microbes on the human vaginal epithelium , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[57] T. Cover,et al. Helicobacter pylori VacA, a paradigm for toxin multifunctionality , 2005, Nature Reviews Microbiology.
[58] K. Robinson,et al. Host adaptation and immune modulation are mediated by homologous recombination in Helicobacter pylori. , 2005, The Journal of infectious diseases.
[59] J. Rivera,et al. The Helicobacter pylori VacA cytotoxin activates RBL‐2H3 cells by inducing cytosolic calcium oscillations , 2004, Cellular microbiology.
[60] K. Sugano,et al. Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. , 2005, The Journal of clinical endocrinology and metabolism.
[61] M. Washington,et al. Activation of beta-catenin by carcinogenic Helicobacter pylori. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[62] B. Neilan,et al. Description of 'Candidatus Helicobacter heilmannii' based on DNA sequence analysis of 16S rRNA and urease genes. , 2004, International journal of systematic and evolutionary microbiology.
[63] John Bertin,et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island , 2004, Nature Immunology.
[64] Y. Sugisaki,et al. Effect of Helicobacter pylori Infection on Ghrelin Expression in Human Gastric Mucosa , 2004, The American Journal of Gastroenterology.
[65] S. Perry. Helicobacter pylori Infection Modifies Immune Response to M. tuberculosis Infection , 2004 .
[66] H. Isomoto,et al. Low plasma ghrelin levels in patients with Helicobacter pylori-associated gastritis. , 2004, The American journal of medicine.
[67] P. Correa,et al. Helicobacter pylori Arginase Inhibits T Cell Proliferation and Reduces the Expression of the TCR ζ-Chain (CD3ζ)1 , 2004, The Journal of Immunology.
[68] Mark S. Sundrud,et al. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[69] Martin J Blaser,et al. Bacterial biota in the human distal esophagus , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[70] Joseph K McLaughlin,et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. , 2004, Journal of the National Cancer Institute.
[71] M. Fujimiya,et al. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[72] B. P. Guo,et al. Molecular cloning and characterization of two Helicobacter pylori genes coding for plasminogen-binding proteins , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[73] M. Blaser,et al. Helicobacter pylori persistence: biology and disease. , 2004, The Journal of clinical investigation.
[74] Z. Ackerman,et al. Role of Helicobacter pylori Infection in Complications from Meckel's Diverticulum , 2003, Digestive Diseases and Sciences.
[75] P. Correa,et al. Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta). , 2004, Journal of immunology.
[76] H. Brenner,et al. Helicobacter pylori colonization and diarrhoeal illness: Results of a population-based cross-sectional study in adults , 2004, European Journal of Epidemiology.
[77] M. D’Elios,et al. The Helicobacter pylori Vacuolating Toxin Inhibits T Cell Activation by Two Independent Mechanisms , 2003, The Journal of experimental medicine.
[78] T. Cover,et al. Cellular Vacuolation and Mitochondrial Cytochrome c Release Are Independent Outcomes of Helicobacter pylori Vacuolating Cytotoxin Activity That Are Each Dependent on Membrane Channel Formation* , 2003, Journal of Biological Chemistry.
[79] R. Haas,et al. Helicobacter pylori Vacuolating Cytotoxin Inhibits T Lymphocyte Activation , 2003, Science.
[80] C. Caldas,et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. , 2003, Gastroenterology.
[81] B. Dove,et al. Determinants of Non-toxicity in the Gastric Pathogen Helicobacter pylori* , 2003, Journal of Biological Chemistry.
[82] S. Falkow,et al. pH-Regulated Gene Expression of the Gastric Pathogen Helicobacter pylori , 2003, Infection and Immunity.
[83] S. Falkow,et al. Disruption of the Epithelial Apical-Junctional Complex by Helicobacter pylori CagA , 2003, Science.
[84] H. Randeva,et al. Plasma ghrelin following cure of Helicobacter pylori. , 2003, Gut.
[85] I. Carlstedt,et al. Intracellular and interstitial expression of Helicobacter pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma. , 2003, The Journal of infectious diseases.
[86] R. Haas,et al. Identification and Characterization of Helicobacter pylori Genes Essential for Gastric Colonization , 2003, The Journal of experimental medicine.
[87] M. S. McClain,et al. Essential Role of a GXXXG Motif for Membrane Channel Formation by Helicobacter pylori Vacuolating Toxin* , 2003, The Journal of Biological Chemistry.
[88] M. Stephens,et al. Traces of Human Migrations in Helicobacter pylori Populations , 2003, Science.
[89] T. Cover,et al. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. , 2003, Cancer research.
[90] M. Selbach,et al. The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c‐Src inactivation , 2003, The EMBO journal.
[91] N. Jones,et al. Helicobacter pylori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein , 2003, Cellular microbiology.
[92] D. Kelly,et al. Role of the thioredoxin system and the thiol-peroxidases Tpx and Bcp in mediating resistance to oxidative and nitrosative stress in Helicobacter pylori. , 2003, Microbiology.
[93] S. Suerbaum,et al. Helicobacter pylori infection , 2013, Nature Reviews Disease Primers.
[94] T. Cover,et al. Two Different Families of hopQ Alleles in Helicobacter pylori , 2002, Journal of Clinical Microbiology.
[95] C. Caldas,et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. , 2002, Journal of the National Cancer Institute.
[96] S. Falkow,et al. Cag pathogenicity island-specific responses of gastric epithelial cells to Helicobacter pylori infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[97] Takeshi Azuma,et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[98] C. Sasakawa,et al. Grb2 is a key mediator of helicobacter pylori CagA protein activities. , 2002, Molecular cell.
[99] D. Graham,et al. Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. , 2002, Gastroenterology.
[100] B. P. Guo,et al. Rapid genetic analysis of Helicobacter pylori gastric mucosal colonization in suckling mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[101] D. Philpott,et al. Reduced activation of inflammatory responses in host cells by mouse‐adapted Helicobacter pylori isolates , 2002, Cellular microbiology.
[102] R. Rappuoli,et al. Isogenic mutants of the cag pathogenicity island of Helicobacter pylori in the mouse model of infection: effects on colonization efficiency. , 2002, Microbiology.
[103] T. Hirayama,et al. Cutting Edge: VacA, a Vacuolating Cytotoxin of Helicobacter pylori, Directly Activates Mast Cells for Migration and Production of Proinflammatory Cytokines1 , 2002, The Journal of Immunology.
[104] M. Blaser,et al. Evidence that cagA+Helicobacter pylori strains are disappearing more rapidly than cagA− strains , 2002, Gut.
[105] M. Selbach,et al. Src Is the Kinase of the Helicobacter pylori CagA Protein in Vitro and in Vivo * , 2002, The Journal of Biological Chemistry.
[106] L. Hammarström,et al. Helicobacter pylori SabA Adhesin in Persistent Infection and Chronic Inflammation , 2002, Nature Reviews Molecular Cell Biology.
[107] R. Haas,et al. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin‐8 , 2003, Molecular microbiology.
[108] Takeshi Azuma,et al. SHP-2 Tyrosine Phosphatase as an Intracellular Target of Helicobacter pylori CagA Protein , 2001, Science.
[109] O. Berg,et al. Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[110] A. Gobert,et al. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: A strategy for bacterial survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[111] Gábor Szabó,et al. A 12-Amino-Acid Segment, Present in Type s2 but Not Type s1 Helicobacter pylori VacA Proteins, Abolishes Cytotoxin Activity and Alters Membrane Channel Formation , 2001, Journal of bacteriology.
[112] D. Passaro,et al. Acute Helicobacter pylori infection is followed by an increase in diarrheal disease among Peruvian children. , 2001, Pediatrics.
[113] M. Blaser,et al. Heterogeneity of Helicobacter pylori cag genotypes in experimentally infected mice. , 2001, FEMS microbiology letters.
[114] T. Azuma,et al. Gastric leptin and Helicobacter pyloriinfection , 2001, Gut.
[115] M. Blaser,et al. Helicobacter pylori genetic diversity and risk of human disease. , 2001, The Journal of clinical investigation.
[116] F. Mégraud,et al. cagA Status and Eradication Treatment Outcome of Anti-Helicobacter pylori Triple Therapies in Patients with Nonulcer Dyspepsia , 2001, Journal of Clinical Microbiology.
[117] M. Blaser,et al. Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. , 2001, The Journal of clinical investigation.
[118] S. Falkow,et al. Vacuolating Cytotoxin of Helicobacter pylori Plays a Role during Colonization in a Mouse Model of Infection , 2001, Infection and Immunity.
[119] David B. Schauer,et al. Emergence of Diverse HelicobacterSpecies in the Pathogenesis of Gastric and Enterohepatic Diseases , 2001, Clinical Microbiology Reviews.
[120] Y. Shiratori,et al. Virulence Factors of Helicobacter pylori Responsible for Gastric Diseases in Mongolian Gerbil , 2000, The Journal of experimental medicine.
[121] J. Chambard,et al. The N‐terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release , 2000, The EMBO journal.
[122] M. Blaser,et al. Inverse relationship between gastric colonization of Helicobacter pylori and diarrheal illnesses in children: results of a population-based cross-sectional study. , 2000, The Journal of infectious diseases.
[123] M. Blaser,et al. Caga-positive strains of Helicobacter pylori may protect against Barrett's esophagus , 2000, American Journal of Gastroenterology.
[124] D. Graham,et al. A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[125] Mark T. Whary,et al. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy , 2000, Nature Medicine.
[126] M. Carrington,et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.
[127] R. Haas,et al. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. , 2000, Science.
[128] L. Brown. Helicobacter pylori: epidemiology and routes of transmission. , 2000, Epidemiologic reviews.
[129] S. Falkow,et al. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[130] D. Relman,et al. Bacterial diversity within the human subgingival crevice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[131] C. Prinz,et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[132] R. Rappuoli,et al. Formation of anion‐selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity , 1999, The EMBO journal.
[133] M. Blaser,et al. Role of Helicobacter pylori cagA+ strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia , 1999, International journal of cancer.
[134] M. Blaser,et al. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. , 1999, The Journal of infectious diseases.
[135] C. Brändén,et al. Antibacterial peptide from H. pylori , 1999, Nature.
[136] F. Mégraud,et al. Geographic distribution of vacA allelic types of Helicobacter pylori. , 1999, Gastroenterology.
[137] D. Czajkowsky,et al. The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[138] J. M. Smith,et al. Free recombination within Helicobacter pylori. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[139] M. Blaser,et al. Experimental Infection of Mongolian Gerbils with Wild-Type and Mutant Helicobacter pylori Strains , 1998, Infection and Immunity.
[140] R. Rappuoli,et al. The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[141] M. Blaser,et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. , 1998, Gastroenterology.
[142] W. Quint,et al. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. , 1998, Gastroenterology.
[143] H. Lönroth,et al. Induction of B cell responses in the stomach of Helicobacter pylori- infected subjects after oral cholera vaccination. , 1998, The Journal of clinical investigation.
[144] L. Engstrand,et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. , 1998, Science.
[145] R. Rappuoli,et al. Selective Inhibition of Ii-dependent Antigen Presentation by Helicobacter pylori Toxin VacA , 1998, The Journal of experimental medicine.
[146] R. Hiatt,et al. Seroprevalence of CagA-positive strains among Helicobacter pylori-infected, healthy young adults. , 1997, The Journal of infectious diseases.
[147] M. Blaser,et al. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. , 1997, Gastroenterology.
[148] M. Borodovsky,et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[149] M. Blaser,et al. Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. , 1996, The Journal of infectious diseases.
[150] E. Lesaffre,et al. Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. , 1996, International journal of epidemiology.
[151] M. Monteiro,et al. Lipopolysaccharides of Helicobacter pylori strains P466 and MO19: structures of the O antigen and core oligosaccharide regions. , 1996, Biochemistry.
[152] E. Kuipers,et al. Helicobacter pylori and atrophic gastritis: importance of the cagA status. , 1996, Journal of the National Cancer Institute.
[153] M. Blaser,et al. Mosaicism in Vacuolating Cytotoxin Alleles of Helicobacter pylori , 1995, The Journal of Biological Chemistry.
[154] M. Blaser,et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. , 1995, Cancer research.
[155] M. Zerial,et al. Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[156] F. Mégraud,et al. The cohort effect and Helicobacter pylori. , 1993, The Journal of infectious diseases.
[157] M. Blaser,et al. Purification and characterization of the vacuolating toxin from Helicobacter pylori. , 1992, Journal of Biological Chemistry.
[158] I. Helander,et al. Low biological activity of Helicobacter pylori lipopolysaccharide , 1992, Infection and immunity.
[159] W. Karnes,et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. , 1991, Gastroenterology.
[160] B. Marshall,et al. Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. , 1990, Gastroenterology.
[161] D. Zavala,et al. Risk factors of gastric precancerous lesions in a high-risk Colombian population. I. Salt. , 1990, Nutrition and cancer.
[162] M. Blaser,et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. , 1989, The New England journal of medicine.
[163] B. Marshall,et al. PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI , 1988, The Lancet.
[164] D. Graham. Campylobacter pylori and Barrett's esophagus. , 1988, Mayo Clinic proceedings.
[165] M. Blaser,et al. Campylobacter pylori antibodies in humans. , 1988, Annals of internal medicine.
[166] M. Dixon,et al. Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. , 1987, Journal of clinical pathology.
[167] A. Lee,et al. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. , 1986, The Journal of infectious diseases.
[168] B. Marshall,et al. UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATION , 1984, The Lancet.